Recent research has demonstrated that ATRX in-frame fusion neuroblastomas are sensitive to the enhancer of zeste homolog 2 (EZH2) inhibition by modulating neuronal gene signatures [129]. The gene discussed is ATRX; the disease is neuroblastoma.